drugset / Trial / NCT00886964
Hepatitis B Vaccination (HBV) in HIV Infected Children
Phase 2
Completed
80 enrolled
The HIV Netherlands Australia Thailand Research Collaboration
ART AIDS Charity Fund · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is : * To evaluate prevalence of protective hepatitis B antibody comparing intradermal (ID) and intramuscular (IM) route in antiHbsAb negative HIV infected children treated with highly active antiretroviral therapy (HAART) * To revaccinate the HBV vaccine in the children who didn't have protective HBV Ab
Timeline
- Start
- 2009-04
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Engerix-B | Vaccine | 2 ug | Other |